Portland, ME, United States of America

Richard T Coughlin


Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 200(Granted Patents)


Location History:

  • Leicester, MA (US) (1993 - 2001)
  • Portland, ME (US) (2011 - 2013)

Company Filing History:


Years Active: 1993-2013

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Richard T Coughlin: Innovator in Granulocytic Ehrlichia Research

Introduction

Richard T Coughlin is a notable inventor based in Portland, ME (US). He has made significant contributions to the field of biomedical research, particularly in the study of granulocytic ehrlichia. With a total of 9 patents to his name, Coughlin has demonstrated a commitment to advancing scientific knowledge and developing innovative solutions.

Latest Patents

Coughlin's latest patents focus on the characterization of granulocytic ehrlichia and methods of use. One of his inventions relates to polypeptides having antigenic epitopes from granulocytic ehrlichia (GE) proteins and their applications. Another patent involves methods for screening samples obtained from subjects for antibodies related to granulocytic ehrlichia (GE) infection. These inventions highlight his expertise in infectious diseases and immunology.

Career Highlights

Throughout his career, Coughlin has worked with several prominent companies, including Aquila Biopharmaceuticals Inc. and Antigenics, Inc. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Coughlin has collaborated with notable colleagues such as Cheryl Murphy and James Storey. These partnerships have further enriched his research and innovation efforts.

Conclusion

Richard T Coughlin is a distinguished inventor whose work in granulocytic ehrlichia research has led to significant advancements in the field. His numerous patents and collaborations reflect his dedication to improving public health through innovative scientific solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…